Cross-source evidence timeline
Nafarelin research timeline
Follow 28 selected, directly cited source records from February 13, 1990 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin.↗
PubMed lists PMID 2533526 in Clinical endocrinology as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1989-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1989 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2019
Literature metadata
A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.↗
PubMed lists PMID 9209899 in Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1997-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 1997 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.↗
PubMed lists PMID 1834049 in The Australian & New Zealand journal of obstetrics & gynaecology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1991-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 1991 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Iontophoresis of nafarelin across human skin in vitro.↗
PubMed lists PMID 8860440 in Pharmaceutical research as Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1996-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 1996 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study.↗
PubMed lists PMID 9720832 in European journal of obstetrics, gynecology, and reproductive biology as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 1998 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.↗
PubMed lists PMID 1533376 in Fertility and sterility as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 1992 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
A comparison of nafarelin acetate and danazol in the treatment of endometriosis.↗
PubMed lists PMID 2140996 in Fertility and sterility as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1990-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 1990 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.↗
PubMed lists PMID 9389816 in Fertility and sterility as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1997-11 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 1997 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Nafarelin in the management of endometriosis: quality of life assessment.↗
PubMed lists PMID 1531576 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1992-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1992 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Nafarelin in the treatment of pelvic pain caused by endometriosis.↗
PubMed lists PMID 2137972 in American journal of obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1990 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Comparison of the pharmacology of nafarelin and danazol.↗
PubMed lists PMID 2137975 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1990 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Nafarelin versus danazol in the treatment of endometriosis.↗
PubMed lists PMID 2137976 in American journal of obstetrics and gynecology as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1990 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Severe hyperkalaemia with nafarelin.↗
PubMed lists PMID 8569395 in Lancet (London, England) as Case Reports, Letter, with publication-date metadata of 1996-02-03 (day precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 3, 1996 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.↗
PubMed lists PMID 11495415 in Journal of assisted reproduction and genetics as Case Reports, Journal Article, with publication-date metadata of 2001-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 2001 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.↗
PubMed lists PMID 2970910 in Clinical pharmacology and therapeutics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 1988-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1988 · month precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02865681↗
PeptideScanner retained ClinicalTrials.gov record NCT02865681 at 2026-11-16T01:35:57.709Z. Its registry update date was 2019-03-19, and PeptideScanner's reviewed identity mapping was nafarelin.↗
Added to PeptideScanner November 16, 2026
Source year
2018
Literature metadata
[Some possibilities for application of "Pfizer" medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice].↗
PubMed lists PMID 18173008 in Akusherstvo i ginekologiia as Journal Article, Review, with publication-date metadata of 2007 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2007 · year precisionAdded to PeptideScanner November 16, 2026
Source year
2017
Literature metadata
[The use of Synarel (nafarelin acetate--spray) in gynecology].↗
PubMed lists PMID 7485786 in Akusherstvo i ginekologiia as Journal Article, with publication-date metadata of 1994 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 1994 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
[Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis].↗
PubMed lists PMID 11526758 in Ginekologia polska as Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 2001 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2016
Literature metadata
Endometriosis with a pleural effusion and ascites. Report of a case treated with nafarelin acetate.↗
PubMed lists PMID 7473446 in The Journal of reproductive medicine as Case Reports, Journal Article, with publication-date metadata of 1995-07 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 1995 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2013
Literature metadata
Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature.↗
PubMed lists PMID 10900582 in The Journal of reproductive medicine as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2000-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 2000 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Nafarelin: a new medical therapy for endometriosis.↗
PubMed lists PMID 2137620 in Progress in clinical and biological research as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 1990 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 1990 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Role of nafarelin in the management of endometriosis.↗
PubMed lists PMID 2533616 in The Journal of reproductive medicine as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1989-12 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 1989 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Clinical experience treating endometriosis with nafarelin.↗
PubMed lists PMID 2533617 in The Journal of reproductive medicine as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1989-12 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 1989 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Experience in the use of nafarelin for treatment of benign breast disease.↗
PubMed lists PMID 2535115 in British journal of clinical practice. Supplement as Clinical Trial, Journal Article, with publication-date metadata of 1989-11 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 1989 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2008
Clinical trials
ClinicalTrials.gov record NCT00034047↗
PeptideScanner retained ClinicalTrials.gov record NCT00034047 at 2026-11-16T01:35:57.709Z. Its registry update date was 2008-01-25, and PeptideScanner's reviewed identity mapping was nafarelin.↗
Added to PeptideScanner November 16, 2026
Source year
2007
Literature metadata
Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group.↗
PubMed lists PMID 2028837 in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1991-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1991 · month precisionAdded to PeptideScanner November 16, 2026
Source year
1990
Regulatory
Drugs@FDA application NDA019886↗
The official Drugs@FDA dataset lists original submission 1 for NDA 019886 with status AP dated 1990-02-13, and names nafarelin acetate among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026